Explore

Trendline Trendline
Alida Biosciences Introduces EpiPlex Tri-Mod Service for Enhanced RNA Modification Profiling

Alida Biosciences Introduces EpiPlex Tri-Mod Service for Enhanced RNA Modification Profiling

Alida Biosciences Introduces EpiPlex Tri-Mod Service for Enhanced RNA Modification Profiling
Trendline Trendline
AI-Designed Protein Switches Revolutionize Low-Cost Biosensors for Medicine and Environment

AI-Designed Protein Switches Revolutionize Low-Cost Biosensors for Medicine and Environment

AI-Designed Protein Switches Revolutionize Low-Cost Biosensors for Medicine and Environment
Rapid Read Rapid Read
Raman Spectroscopy Uncovers New Cyanobacterial Pigment

Raman Spectroscopy Uncovers New Cyanobacterial Pigment

Researchers have identified a novel cyanobacterial pigment using Raman spectroscopy, a technique that allows for precise in situ identification of molecular structures. The study focused on the cyanobacterium Chamaesiphon polonicus, revealing a pigment with unique vibrational signatures distinct from known pigments like scytonemin and gloeocapsin. This discovery expands the understanding of microbial photoprotection and suggests the existence of a new class of UV-screening pigments. The research highlights the potential of Raman spectroscopy in microbial pigment discovery and its applications in ecological and evolutionary studies.
Rapid Read Rapid Read
Korean Research Team Develops AI-Driven Protein to Recognize Stress Hormones

Korean Research Team Develops AI-Driven Protein to Recognize Stress Hormones

A research team from the Korea Advanced Institute of Science and Technology (KAIST) has successfully developed a protein that can selectively recognize the stress hormone cortisol using a deep learning-driven protein structure generation and sequence design method. This innovation involves the de novo design of small molecule-binding proteins, which are transformed into sensors similar to chemical-induced dimerization (CID). The team utilized the NTF2-like fold as the core universal backbone to achieve high affinity and specificity in biosensing applications. This breakthrough addresses the longstanding challenge in life sciences and synthetic biology of designing proteins with both high affinity and specificity for small molecules. The research results have been published in Nature Communications, highlighting the potential applications in disease diagnosis, new drug development, and environmental monitoring.
Rapid Read Rapid Read
Researchers Develop Molecular 'Light Switch' for Oxytocin to Study Brain Functions

Researchers Develop Molecular 'Light Switch' for Oxytocin to Study Brain Functions

Researchers at the University of Queensland have developed a molecular 'light switch' for the hormone oxytocin, often referred to as the 'love hormone'. This innovation allows scientists to release oxytocin in the brain with high precision using light, enabling the study of its effects on individual synapses, neurons, and neuronal circuits. The research, led by Professor Markus Muttenthaler, aims to provide insights into how social behaviors and emotions are wired in the brain. Oxytocin is known to play a crucial role in social connections, including trust, bonding, and emotional regulation. The study, published in Angewandte Chemie International Edition, could lead to improved therapies for conditions linked to changes in oxytocin signaling, such as autism, anxiety, and depression.
Rapid Read Rapid Read
KAIST Researchers Develop AI-Driven Biosensor for Stress Hormone Detection

KAIST Researchers Develop AI-Driven Biosensor for Stress Hormone Detection

A research team from the Korea Advanced Institute of Science and Technology (KAIST) has developed a novel artificial intelligence biosensor capable of detecting the stress hormone cortisol. Utilizing a deep learning-driven protein structure generation and sequence design method, the team designed small molecule-binding proteins with high specificity. The proteins were transformed into sensors that can selectively recognize cortisol, addressing a significant challenge in protein design. This advancement moves beyond traditional methods that relied on natural protein screening and modification, offering a scalable and universal approach to biosensing technology.
Trendline Trendline
Sartorius Introduces Next-Generation Cloning Method for Monoclonal Cell Lines

Sartorius Introduces Next-Generation Cloning Method for Monoclonal Cell Lines

Sartorius Introduces Next-Generation Cloning Method for Monoclonal Cell Lines
Trendline Trendline
Invivoscribe Launches PrepQuant System to Enhance Molecular Testing Consistency

Invivoscribe Launches PrepQuant System to Enhance Molecular Testing Consistency

Invivoscribe Launches PrepQuant System to Enhance Molecular Testing Consistency
Trendline Trendline
AI-Generated Proteins Developed as Smart Molecular Sensors by International Team

AI-Generated Proteins Developed as Smart Molecular Sensors by International Team

AI-Generated Proteins Developed as Smart Molecular Sensors by International Team
Rapid Read Rapid Read
Israeli Researcher Explores Reversible Aging and Disease Prevention

Israeli Researcher Explores Reversible Aging and Disease Prevention

Prof. Debbie Toiber, a molecular biologist at Ben-Gurion University of the Negev, is conducting research to understand the mechanisms of aging and prevent age-related diseases. Her work focuses on neurodegenerative diseases such as Alzheimer's and Parkinson's, aiming to identify early disruptions in cellular processes that lead to pathological aging. By studying animal models and human cells, Toiber seeks to detect decision points where cells choose between healthy and pathological aging. Her research involves using chemical reactions and stem cell technology to study brain cells, with the goal of steering them towards healthier aging trajectories.
Rapid Read Rapid Read
Oregon State University Researchers Develop Promising Lung Cancer Treatment Using Lipid Nanoparticles

Oregon State University Researchers Develop Promising Lung Cancer Treatment Using Lipid Nanoparticles

Researchers at Oregon State University have developed a novel approach to address two major challenges associated with lung cancer: tumor growth and severe muscle loss. Their study, published in the Journal of Controlled Release, explores the use of lipid nanoparticles to deliver genetic material directly to cancer cells in the lungs. These nanoparticles are engineered to carry follistatin messenger RNA, which instructs cells to produce follistatin, a protein that slows tumor progression and supports muscle growth. The lipid nanoparticles are administered through the bloodstream and are directed to lung cancer tumors by binding with vitronectin, a protein found in blood serum. This method has shown a 2.5-fold greater reduction in tumor burden compared to conventional lipid nanoparticles, which tend to accumulate in the liver.
Rapid Read Rapid Read
Stanford Researchers Develop Ultrasound-Activated Nanoparticles for Deep-Tissue Light Therapy

Stanford Researchers Develop Ultrasound-Activated Nanoparticles for Deep-Tissue Light Therapy

Researchers at Stanford University have developed a groundbreaking nanotechnology that uses non-invasive ultrasound to create light inside the body. This innovation allows for the delivery of light to any part of the body without the need for invasive procedures. The technology involves mechanoluminescent nanoparticles that emit blue light when stimulated by ultrasound waves. These nanoparticles are coated with a biocompatible material and can be injected into the bloodstream, where they travel throughout the body. The research demonstrated the ability to generate light in multiple locations simultaneously, offering precise control over light emission. This method has potential applications in various medical fields, including surgery and targeted therapies, by overcoming the limitations of light penetration in tissues.